Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
TDOC 
Teladoc Inc (TDOC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/08/2025: TDOC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
24 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $9.12
1 Year Target Price $9.12
| 3 | Strong Buy |
| 2 | Buy |
| 19 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -19.47% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/08/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.23B USD | Price to earnings Ratio - | 1Y Target Price 9.12 |
Price to earnings Ratio - | 1Y Target Price 9.12 | ||
Volume (30-day avg) 24 | Beta 1.77 | 52 Weeks Range 6.35 - 15.21 | Updated Date 08/9/2025 |
52 Weeks Range 6.35 - 15.21 | Updated Date 08/9/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.15 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-29 | When Before Market | Estimate -0.2632 | Actual -0.1473 |
Profitability
Profit Margin -8.16% | Operating Margin (TTM) -7.29% |
Management Effectiveness
Return on Assets (TTM) -3.57% | Return on Equity (TTM) -14.18% |
Valuation
Trailing PE - | Forward PE 357.14 | Enterprise Value 1585238007 | Price to Sales(TTM) 0.48 |
Enterprise Value 1585238007 | Price to Sales(TTM) 0.48 | ||
Enterprise Value to Revenue 0.62 | Enterprise Value to EBITDA 9.97 | Shares Outstanding 176691008 | Shares Floating 174770035 |
Shares Outstanding 176691008 | Shares Floating 174770035 | ||
Percent Insiders 0.98 | Percent Institutions 74.85 |
Upturn AI SWOT
Teladoc Inc
Company Overview
History and Background
Teladoc Health, Inc. was founded in 2002. It pioneered telehealth by connecting patients with doctors remotely. Initially focused on simple consults, it expanded into chronic care management, mental health, and other specialized areas through acquisitions and internal development.
Core Business Areas
- Teladoc Medical Group: Provides general medical care via phone, video, and app. It connects patients with physicians 24/7 for non-emergency medical issues.
- BetterHelp: Offers online mental health therapy services, connecting individuals with licensed therapists through various communication methods.
- Livongo: Focuses on chronic condition management programs for diabetes, hypertension, and weight management. It provides personalized insights and support.
- InTouch Health: Enterprise telehealth solutions for hospitals and health systems enabling them to offer virtual care to their patients. Teladoc acquired this in 2020 to expand its hospital and health system reach
Leadership and Structure
Jason Gorevic is the CEO. The company operates with a hierarchical structure, with executive leadership overseeing various divisions, including Teladoc Health, BetterHelp, and Livongo. A Board of Directors provides strategic oversight.
Top Products and Market Share
Key Offerings
- General Medical: Virtual doctor visits for common illnesses and injuries. Teladoc has a significant share in the direct-to-consumer telehealth market. Competitors include Amwell (AMWL) and MDLive (acquired by Cigna).
- Mental Health (BetterHelp): Online therapy and counseling services. BetterHelp is a major player in the online therapy space. Competitors include Talkspace and Cerebral.
- Chronic Care Management (Livongo): Programs for managing chronic conditions like diabetes and hypertension. Livongo focuses on providing technology driven personalized care, giving it competitive advantage to other chronic care competitors such as Omada Health, and Vida Health.
Market Dynamics
Industry Overview
The telehealth industry is experiencing rapid growth, driven by increasing demand for convenient and affordable healthcare access, technological advancements, and favorable regulatory changes. The industry is becoming more competitive, with new entrants and established players vying for market share.
Positioning
Teladoc Health is a leading player in the telehealth industry, offering a broad range of services. Its competitive advantages include its established brand, extensive network of providers, and integrated platform.
Total Addressable Market (TAM)
The telehealth TAM is estimated to be in hundreds of billions of USD, with projections varying widely. Teladoc Health, given its diversified offerings, is positioned to capture a substantial portion of this TAM, particularly as telehealth adoption continues to expand.
Upturn SWOT Analysis
Strengths
- Large established customer base
- Comprehensive telehealth platform
- Strong brand recognition
- Extensive network of providers
Weaknesses
- High acquisition costs of integrating acquired companies
- Dependence on partnerships with health plans and employers
- Price competition among telehealth providers
- Regulatory hurdles and uncertainty
Opportunities
- Expanding telehealth services to new geographic markets
- Integrating artificial intelligence (AI) and machine learning (ML) to improve care delivery
- Developing new partnerships with health systems and payers
- Offering specialized telehealth programs for specific conditions
Threats
- Increasing competition from other telehealth providers
- Changing regulations and reimbursement policies
- Data security and privacy concerns
- Potential for economic downturn to reduce healthcare spending
Competitors and Market Share
Key Competitors
- AMWL
- TDOC
- Cigna (MDLive)
Competitive Landscape
Teladoc Health faces intense competition from other telehealth providers, health systems, and technology companies. Its advantages include its brand recognition and comprehensive platform, while its disadvantages include its high valuation and integration challenges.
Major Acquisitions
Livongo
- Year: 2020
- Acquisition Price (USD millions): 18500
- Strategic Rationale: Expanded Teladoc Health's chronic care management capabilities and market reach.
InTouch Health
- Year: 2020
- Acquisition Price (USD millions): 600
- Strategic Rationale: Expanded Teladoc Health's hospital and health system reach.
Growth Trajectory and Initiatives
Historical Growth: Teladoc Health experienced rapid growth in the past decade, fueled by acquisitions and increasing adoption of telehealth. However, growth has slowed in recent years as the market has become more competitive.
Future Projections: Analyst projections for Teladoc Health's future growth vary, depending on the company's ability to execute its strategy and navigate the evolving telehealth landscape. Revenue growth is expected to continue, but profitability remains a key challenge.
Recent Initiatives: Recent strategic initiatives include focusing on profitability, expanding chronic care management programs, and enhancing the user experience on its platform.
Summary
Teladoc Health is a leading telehealth provider with a strong brand and comprehensive platform. While revenue growth continues, achieving profitability remains a key challenge. Intense competition and changing regulations pose threats, but opportunities exist in expanding services and leveraging technology. The company must navigate integration challenges and demonstrate sustainable growth to justify its valuation.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Market Research Reports
- Analyst Estimates
- Industry News
Disclaimers:
The information provided is for informational purposes only and should not be construed as financial advice. Investment decisions should be based on individual due diligence and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Teladoc Inc
Exchange NYSE | Headquaters Purchase, NY, United States | ||
IPO Launch date 2015-07-01 | CEO & Director Mr. Charles Divita III, CPA | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4620 | Website https://www.teladochealth.com |
Full time employees 4620 | Website https://www.teladochealth.com | ||
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counselling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.